Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Clinical trial NCT01398501 · COMPLETED
Trial details
- NCT number
- NCT01398501
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.